Prashanth Reddy

1.1k total citations
17 papers, 432 citations indexed

About

Prashanth Reddy is a scholar working on Neurology, Cognitive Neuroscience and Neurology. According to data from OpenAlex, Prashanth Reddy has authored 17 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 3 papers in Cognitive Neuroscience and 3 papers in Neurology. Recurrent topics in Prashanth Reddy's work include Parkinson's Disease Mechanisms and Treatments (12 papers), Neurological disorders and treatments (10 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). Prashanth Reddy is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (12 papers), Neurological disorders and treatments (10 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). Prashanth Reddy collaborates with scholars based in United Kingdom, Spain and Italy. Prashanth Reddy's co-authors include К. Ray Chaudhuri, Pablo Martínez‐Martín, Angelo Antonini, Michael Samuel, Keyoumars Ashkan, Alexandra Rizos, Anne Martin, Per Odin, Y. Naidu and Antonia Todorova and has published in prestigious journals such as Health and Quality of Life Outcomes, Journal of Neural Transmission and Parkinsonism & Related Disorders.

In The Last Decade

Prashanth Reddy

17 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prashanth Reddy United Kingdom 12 359 75 63 59 54 17 432
Mitsuru Shiba Japan 7 328 0.9× 97 1.3× 66 1.0× 62 1.1× 45 0.8× 13 453
Lydia López Manzanares Spain 10 416 1.2× 79 1.1× 75 1.2× 60 1.0× 41 0.8× 33 487
Dong-Woo Ryu South Korea 12 252 0.7× 67 0.9× 60 1.0× 73 1.2× 33 0.6× 39 346
James W. Bales United States 11 318 0.9× 71 0.9× 262 4.2× 64 1.1× 26 0.5× 16 495
Lynn K. Struck United States 8 305 0.8× 103 1.4× 88 1.4× 69 1.2× 24 0.4× 9 436
Mustafa Siddiqui United States 12 393 1.1× 101 1.3× 57 0.9× 89 1.5× 94 1.7× 33 556
Angelika Nebe Germany 4 336 0.9× 41 0.5× 46 0.7× 42 0.7× 30 0.6× 5 367
Giorgio Tommasi Italy 10 298 0.8× 144 1.9× 18 0.3× 52 0.9× 62 1.1× 10 345
Subhashie Wijemanne United States 11 293 0.8× 140 1.9× 85 1.3× 79 1.3× 44 0.8× 17 467
Pavel Ressner Czechia 7 342 1.0× 132 1.8× 49 0.8× 53 0.9× 32 0.6× 25 414

Countries citing papers authored by Prashanth Reddy

Since Specialization
Citations

This map shows the geographic impact of Prashanth Reddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prashanth Reddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prashanth Reddy more than expected).

Fields of papers citing papers by Prashanth Reddy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prashanth Reddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prashanth Reddy. The network helps show where Prashanth Reddy may publish in the future.

Co-authorship network of co-authors of Prashanth Reddy

This figure shows the co-authorship network connecting the top 25 collaborators of Prashanth Reddy. A scholar is included among the top collaborators of Prashanth Reddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prashanth Reddy. Prashanth Reddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Carroll, Camille, et al.. (2024). Addressing Comorbidities in People with Parkinson’s Disease: Considerations From An Expert Panel. Journal of Parkinson s Disease. 14(1). 53–63. 4 indexed citations
2.
Dafsari, Haidar S., Luisa Weiß, Monty Silverdale, et al.. (2018). Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson's disease. Brain stimulation. 11(4). 867–874. 31 indexed citations
3.
Carroll, Camille, et al.. (2018). Noninvasive Options for ‘Wearing-off’ in Parkinson’s Disease: A Clinical Consensus From a Panel of Uk Parkinson’s Disease Specialists. Neurodegenerative Disease Management. 8(5). 349–360. 19 indexed citations
4.
Dafsari, Haidar S., Paul Reker, Monty Silverdale, et al.. (2017). Subthalamic Stimulation Improves Quality of Life of Patients Aged 61 Years or Older With Short Duration of Parkinson’s Disease. Neuromodulation Technology at the Neural Interface. 21(6). 532–540. 21 indexed citations
5.
Dafsari, Haidar S., Prashanth Reddy, Jan Niklas Petry‐Schmelzer, et al.. (2015). Beneficial Effects of Bilateral Subthalamic Stimulation on Non-Motor Symptoms in Parkinson's Disease. Brain stimulation. 9(1). 78–85. 81 indexed citations
6.
Reddy, Prashanth, Pablo Martínez‐Martín, Richard G. Brown, et al.. (2014). Perceptions of symptoms and expectations of advanced therapy for Parkinson’s disease: preliminary report of a Patient-Reported Outcome tool for Advanced Parkinson’s disease (PRO-APD). Health and Quality of Life Outcomes. 12(1). 11–11. 34 indexed citations
7.
Mao, Peizhong, Charles K. Meshul, Philippe Thuillier, & Prashanth Reddy. (2013). Neurotransmitter CART as a New Therapeutic Candidate for Parkinson’s Disease. Pharmaceuticals. 6(1). 108–123. 19 indexed citations
8.
Todorova, Antonia, Pablo Martínez‐Martín, Anne Martin, et al.. (2013). Daytime apomorphine infusion combined with transdermal Rotigotine patch therapy is tolerated at 2 years: A 24-h treatment option in Parkinson's disease. Research Portal (King's College London). 3(2). 127–130. 12 indexed citations
9.
Reddy, Prashanth, Pablo Martínez‐Martín, Alexandra Rizos, et al.. (2012). Intrajejunal Levodopa Versus Conventional Therapy in Parkinson Disease. Clinical Neuropharmacology. 35(5). 205–207. 44 indexed citations
10.
Ashkan, Keyoumars, Michael Samuel, Prashanth Reddy, & К. Ray Chaudhuri. (2012). The impact of deep brain stimulation on the nonmotor symptoms of Parkinson’s disease. Journal of Neural Transmission. 120(4). 639–642. 19 indexed citations
11.
Rizos, Alexandra, B. Kessel, Pablo Martínez‐Martín, et al.. (2012). Early morning off periods in Parkinson's disease: Characterisation of non motor patterns and treatment effect: An international study. Research Portal (King's College London). 27. 3 indexed citations
12.
Rizos, Alexandra, Pablo Martínez‐Martín, Ana López, et al.. (2012). European multicentre survey of tolerability rates and impulse control behaviour trends of prolonged release dopamine agonists in young and old PD. 27. 7 indexed citations
13.
Martínez‐Martín, Pablo, Prashanth Reddy, Angelo Antonini, et al.. (2011). Chronic Subcutaneous Infusion Therapy with Apomorphine in Advanced Parkinson's Disease Compared to Conventional Therapy: A Real Life Study of Non Motor Effect. Journal of Parkinson s Disease. 1(2). 197–203. 94 indexed citations
14.
Rizos, Alexandra, Amy Martin, S. Tluk, et al.. (2011). 2.258 LONG ACTING DOPAMINE AGONISTS IN CLINICAL PRACTICE: A COMPARATIVE MULTICENTRE EUROPEAN SURVEY IN YOUNG AND OLD PD. Parkinsonism & Related Disorders. 18. S129–S130. 2 indexed citations
15.
Naidu, Y., et al.. (2010). Narcolepsy in Parkinson’s disease. Expert Review of Neurotherapeutics. 10(6). 879–884. 19 indexed citations
16.
Irani, Farzan, et al.. (2009). An endobronchial lipoma mimicking asthma and malignancy. Primary Care Respiratory Journal. 19(3). 281–283. 17 indexed citations
17.
Bharati, Akshar, et al.. (2005). Inferring semantic roles using sub-categorization frames and maximum entropy model. 165–165. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitsuru Shiba Breakdown of academic impact, for papers by Lydia López Manzanares Breakdown of academic impact, for papers by Dong-Woo Ryu Breakdown of academic impact, for papers by James W. Bales Breakdown of academic impact, for papers by Lynn K. Struck Breakdown of academic impact, for papers by Mustafa Siddiqui Breakdown of academic impact, for papers by Angelika Nebe Breakdown of academic impact, for papers by Giorgio Tommasi Breakdown of academic impact, for papers by Subhashie Wijemanne Breakdown of academic impact, for papers by Pavel Ressner
Rankless by CCL
2026